Leah M. Hesse

1.5k total citations
21 papers, 1.2k citations indexed

About

Leah M. Hesse is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Leah M. Hesse has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Leah M. Hesse's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Leah M. Hesse is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Leah M. Hesse collaborates with scholars based in United States, Germany and Finland. Leah M. Hesse's co-authors include Michael H. Court, David J. Greenblatt, Lisa L. von Moltke, Moshe Finel, Soundararajan Krishnaswamy, Qin Hao, Jerold S. Harmatz, Karthik Venkatakrishnan, Su Duan and Xinxin Ding and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Anesthesiology and British Journal of Pharmacology.

In The Last Decade

Leah M. Hesse

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leah M. Hesse United States 17 537 304 242 234 137 21 1.2k
Koujirou Yamamoto Japan 22 493 0.9× 403 1.3× 267 1.1× 165 0.7× 179 1.3× 102 1.4k
Qun‐Ying Yue Sweden 19 835 1.6× 328 1.1× 325 1.3× 187 0.8× 262 1.9× 35 1.6k
Christoph Wandel United States 16 590 1.1× 734 2.4× 280 1.2× 531 2.3× 139 1.0× 41 1.6k
Dolores Ochoa Spain 25 548 1.0× 251 0.8× 207 0.9× 273 1.2× 198 1.4× 98 1.6k
David J. Greenblatt United States 11 492 0.9× 244 0.8× 123 0.5× 154 0.7× 180 1.3× 12 1.1k
Edward J. Randinitis United States 18 232 0.4× 265 0.9× 231 1.0× 371 1.6× 194 1.4× 43 1.3k
George R. Avant United States 16 362 0.7× 249 0.8× 119 0.5× 132 0.6× 152 1.1× 30 1.2k
Miriam Saiz‐Rodríguez Spain 19 351 0.7× 183 0.6× 191 0.8× 176 0.8× 116 0.8× 58 984
Georg Engel Germany 14 291 0.5× 251 0.8× 522 2.2× 128 0.5× 121 0.9× 31 1.6k
Séverine Crettol Switzerland 18 586 1.1× 286 0.9× 289 1.2× 454 1.9× 186 1.4× 40 1.5k

Countries citing papers authored by Leah M. Hesse

Since Specialization
Citations

This map shows the geographic impact of Leah M. Hesse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leah M. Hesse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leah M. Hesse more than expected).

Fields of papers citing papers by Leah M. Hesse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leah M. Hesse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leah M. Hesse. The network helps show where Leah M. Hesse may publish in the future.

Co-authorship network of co-authors of Leah M. Hesse

This figure shows the co-authorship network connecting the top 25 collaborators of Leah M. Hesse. A scholar is included among the top collaborators of Leah M. Hesse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leah M. Hesse. Leah M. Hesse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jensen, Marie Aarrebo, Dominik Soll, Leah M. Hesse, et al.. (2025). Optimizing diagnostic strategies for central adrenal insufficiency in pituitary disease. European Journal of Endocrinology. 192(2). 100–109. 1 indexed citations
2.
Court, Michael H., Xiuling Zhang, Xinxin Ding, et al.. (2011). Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues. Xenobiotica. 42(3). 266–277. 167 indexed citations
3.
He, Xi, Leah M. Hesse, Suwagmani Hazarika, et al.. (2009). Evidence for oxazepam as anin vivoprobe of UGT2B15: oxazepam clearance is reduced byUGT2B15D85Y polymorphism but unaffected byUGT2B17deletion. British Journal of Clinical Pharmacology. 68(5). 721–730. 58 indexed citations
4.
Kummrow, Maya, Florina S. Tseng, Leah M. Hesse, & Michael H. Court. (2008). Pharmacokinetics of Buprenorphine after Single-Dose Subcutaneous Administration in Red-Eared Sliders (Trachemys scripta elegans). Journal of Zoo and Wildlife Medicine. 39(4). 590–595. 39 indexed citations
5.
Toivonen, Päivi, et al.. (2007). Nicotine Glucuronidation and the Human UDP-Glucuronosyltransferase UGT2B10. Molecular Pharmacology. 72(3). 761–768. 85 indexed citations
6.
Hesse, Leah M., David J. Greenblatt, Lisa L. von Moltke, & Michael H. Court. (2006). Ritonavir Has Minimal Impact on the Pharmacokinetic Disposition of a Single Dose of Bupropion Administered to Human Volunteers. The Journal of Clinical Pharmacology. 46(5). 567–576. 30 indexed citations
7.
Krishnaswamy, Soundararajan, Qin Hao, Leah M. Hesse, et al.. (2005). UDP Glucuronosyltransferase (UGT) 1A6 Pharmacogenetics: II. Functional Impact of the Three Most Common Nonsynonymous UGT1A6 Polymorphisms (S7A, T181A, and R184S). Journal of Pharmacology and Experimental Therapeutics. 313(3). 1340–1346. 92 indexed citations
8.
Krishnaswamy, Soundararajan, Qin Hao, Leah M. Hesse, et al.. (2005). UDP Glucuronosyltransferase (UGT) 1A6 Pharmacogenetics: I. Identification of Polymorphisms in the 5′-Regulatory and Exon 1 Regions, and Association with Human Liver UGT1A6 Gene Expression and Glucuronidation. Journal of Pharmacology and Experimental Therapeutics. 313(3). 1331–1339. 44 indexed citations
9.
Patki, Kiran C., Lisa L. von Moltke, Jerold S. Harmatz, et al.. (2004). Effect of Age on in Vitro Triazolam Biotransformation in Male Human Liver Microsomes. Journal of Pharmacology and Experimental Therapeutics. 308(3). 874–879. 28 indexed citations
10.
Hesse, Leah M., Ping He, Soundararajan Krishnaswamy, et al.. (2004). Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes. Pharmacogenetics. 14(4). 225–238. 153 indexed citations
11.
Olubodun, J.O.B., Hermann R. Ochs, Lisa L. von Moltke, et al.. (2003). Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men. British Journal of Clinical Pharmacology. 56(3). 297–304. 80 indexed citations
12.
Hesse, Leah M., Lisa L. von Moltke, & David J. Greenblatt. (2003). Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon. CNS Drugs. 17(7). 513–532. 63 indexed citations
13.
Hesse, Leah M., Yumiko Sakai, Daesety Vishnuvardhan, et al.. (2003). Effect of bupropion on CYP2B6 and CYP3A4 catalytic activity, immunoreactive protein and mRNA levels in primary human hepatocytes: comparison with rifampicin. Journal of Pharmacy and Pharmacology. 55(9). 1229–1239. 23 indexed citations
14.
Hesse, Leah M., Yumiko Sakai, Daesety Vishnuvardhan, et al.. (2003). Effect of bupropion on CYP2B6 and CYP3A4 catalytic activity, immunoreactive protein and mRNA levels in primary human hepatocytes: comparison with rifampicin. Journal of Pharmacy and Pharmacology. 55(12). 1707–1707. 2 indexed citations
15.
Moltke, Lisa L. von, James L. Weemhoff, Michael Perloff, et al.. (2002). Effect of zolpidem on human Cytochrome P450 activity, and on transport mediated by P‐glycoprotein. Biopharmaceutics & Drug Disposition. 23(9). 361–367. 25 indexed citations
16.
Court, Michael H., Su Duan, Leah M. Hesse, Karthik Venkatakrishnan, & David J. Greenblatt. (2001). Cytochrome P-450 2B6 Is Responsible for Interindividual Variability of Propofol Hydroxylation by Human Liver Microsomes. Anesthesiology. 94(1). 110–119. 162 indexed citations
17.
Theoharides, Theoharis C., William Boucher, Richard Létourneau, et al.. (2000). Chondroitin sulphate inhibits connective tissue mast cells. British Journal of Pharmacology. 131(6). 1039–1049. 51 indexed citations
18.
Theoharides, Theoharis C., Richard Létourneau, Leah M. Hesse, et al.. (1999). Stress-induced rat intestinal mast cell intragranular activation and inhibitory effect of sulfated proteoglycans.. PubMed. 44(8 Suppl). 87S–93S. 26 indexed citations
19.
Hesse, Leah M., et al.. (1968). [Determination of the glomerular filtration rate with 51Cr-EDTA in nuclear medicine].. PubMed. 109(3). 360–5. 1 indexed citations
20.
Hesse, Leah M., et al.. (1967). Vergleichende Untersuchungen der glomerulären Filtrationsrate mit Co-57-Cyanocobalamin und J-131-Chlorjodpropylinulin. Journal of Molecular Medicine. 45(11). 573–575. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026